Tag: Hepatitis
Model Shows Hep C-Infected Kidney Transplants Beneficial, Cost-Effective
Transplant plus antiviral therapy improves quality of life, reduces health care costs for recipients
CDC: Prevalence of Any Past, Present Hep B Infection 4.3 Percent
Prevalence of HBV higher for men than women; vaccination higher among women than men
Hep C Testing, Treatment Rates Low at Federally Qualified Health Centers
Only 15 percent of individuals with identified opioid use disorder were tested for hepatitis C virus
Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
Risk for 10-year liver-related mortality also lower among aspirin users with chronic hepatitis B or C
Less Than 1 in 4 Perinatally Exposed Infants Tested for Hep C
Rate of testing significantly lower among African-American infants
USPSTF Recommends Screening All Adults for Hepatitis C Virus
B recommendation applies to all asymptomatic adults ages 18 to 79 years regardless of risk
Heart Transplants From Hep C Virus-Positive Donors Seem Safe
No significant difference seen in one-year posttransplant survival for HCV+, HCV− donors
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART
Outcomes of Hep C Screening Intervention Examined
48.1 percent of baby boomers screened for HCV, varying from 19.8 to 71.3 percent by practice
Treatment Response Rates High for Seniors With Hep C Infection
Sustained virologic response rates similar for patients 65 years and older, patients younger than 65 years
